FDA Approves Opioid Reversal Drug Narcan for Over-the-Counter Use
- March 31, 2023
The Food and Drug Administration (FDA) approved March 29 Emergent BioSolutions Inc.’s opioid overdose reversal drug Narcan as the first naloxone product for use without a prescription.
ARTICLE TAGS
You must be logged in to access this content.